Fate Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx |
|---|---|---|---|
| FY2016 | $-29.8M | $-30.3M | $457.0K |
| FY2017 | $-36.8M | $-38.5M | $1.7M |
| FY2018 | $-38.7M | $-41.0M | $2.3M |
| FY2019 | $-83.2M | $-90.6M | $7.4M |
| FY2020 | $-39.2M | $-44.2M | $4.9M |
| FY2021 | $-162.9M | $-213.6M | $50.7M |
| FY2022 | $-248.2M | $-283.8M | $35.6M |
| FY2023 | $-132.3M | $-138.4M | $6.2M |
| FY2024 | $-122.9M | $-123.6M | $730.0K |
| FY2025 | $-106.1M | $-112.0M | $6.0M |